OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New advances in the treatments of drug-resistant tuberculosis
M. Mahmoud, Yurong Tan
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 8, pp. 863-870
Closed Access | Times Cited: 11

Showing 11 citing articles:

Application of CRISPR–cas-based technology for the identification of tuberculosis, drug discovery and vaccine development
Liqin Shi, Ruiqi Gu, Jinzhao Long, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 6

Breaking barriers: The potential of nanosystems in antituberculosis therapy
Christian S. Carnero Canales, Jessica Ingrid Marquez Cazorla, Renzo Marianito Marquez Cazorla, et al.
Bioactive Materials (2024) Vol. 39, pp. 106-134
Open Access | Times Cited: 3

Correlation between notifiable infectious diseases and transportation passenger traffic from 2013 to 2019 in mainland China
Cuiping Xia, Jinyu Wang, Zhongxing Wang, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs
George J. Kontoghiorghes
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16749-16749
Open Access | Times Cited: 6

Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery
Matteo Mori, Stefania Villa, Laurent R. Chiarelli, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1559-1559
Open Access | Times Cited: 3

From crisis to cure: harnessing the potential of mycobacteriophages in the battle against tuberculosis
Noura M Bin Yahia, Minghai Shan, Yue Zhu, et al.
Journal of Applied Microbiology (2024) Vol. 135, Iss. 8
Open Access

Decoding drug resistance in mycobacterium tuberculosis complex: genetic insights and future challenges
Amey Deshpande, Rupali Likhar, Tabassum Khan, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 7, pp. 511-527
Closed Access

DOTTs-Database of Therapeutic Plants against Tuberculosis: Rationalizing traditional medicine for therapeutic applications
Risha Hazarika, Tarun Gangar, Sanjukta Patra
European Journal of Integrative Medicine (2024), pp. 102409-102409
Closed Access

Advancements and Challenges in Tuberculosis Drug Discovery: A Comprehensive Overview
Puja Kumari Agnivesh, Arnab Roy, Shashikanta Sau, et al.
Microbial Pathogenesis (2024) Vol. 198, pp. 107074-107074
Closed Access

Bacteriophage therapy in the era of bacterial resistance: future prospects
Fan Yang, Chunyi Zhou, Yurong Tan, et al.
Reviews in Medical Microbiology (2024)
Closed Access

Page 1

Scroll to top